Resolution of an Infection with Leishmania braziliensis Confers Complete Protection to a Subsequent Challenge with Leishmania major in BALB/c Mice

Memorias do Instituto Oswaldo Cruz

Volumn 94, Issue 1, 1999, Pages 71-76

  Lima, Hermenio C ^a,b   DeKrey, Gregory K ^a   Titus, Richard G ^a  

^a Department of Environmental and Radiological Health Sciences   (United States)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Cross protection; Cytokines; Leishmania braziliensis; Leishmania major; Mice

Indexed keywords

LEISHMANIA BRAZILIENSIS; LEISHMANIA MAJOR;

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4;

ANIMAL; ARTICLE; BAGG ALBINO MOUSE; FEMALE; IMMUNOLOGY; LEISHMANIA BRAZILIENSIS; LEISHMANIA MAJOR; MOUSE; SKIN LEISHMANIASIS;

ANIMALS; CYTOKINES; FEMALE; INTERFERON TYPE II; INTERLEUKIN-4; LEISHMANIA BRAZILIENSIS; LEISHMANIA MAJOR; LEISHMANIASIS, CUTANEOUS; MICE; MICE, INBRED BALB C;

EID: 0032619565     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761999000100015     Document Type: Article

References (31)

1. Abramson MA, Dietze R, Frucht DM, Schwantz R, Kenney RT 1995. Comparison of New and Old World leishmaniasis in an endemic region of Brazil. Clin Infect Dis 20: 1292-1297.
2. Alexander J 1988. Sex differences and cross-immunity in DBA/2 mice infected with L. mexicana and L. major. Parasitology 96: 297-302.
3. Alexander J, Phillips RS 1978a. Leishmania mexicana and L. tropica: inhibition of growth in mice by concurrent infections of Trypanosoma brucei. Exp Parasitol 44: 136-142.
4. Alexander J, Phillips RS 1978b. Leishmania tropica and Leishmania mexicana: cross-immunity in mice. Exp Parasitol 45:93-100.
5. Bogdan C, Gessner A, Rollinghoff M 1993. Cytokines in leishmaniasis: a complex network of stimulatory and inhibitory interactions. Immunobiology 189: 356-396.
6. Childs GE, Lighther LK, McKinney LA, Groves M, Price E, Hendricks L 1984. Inbred mice as model hosts for cutaneous leishmaniasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana and L. aethiopica. Ann Trop Med Parasitol 78: 25-34.
7. da Silva RP, Hall BF, Joiner KA, Sacks DL 1989. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages. J Immunol 143: 617-622.
8. DeKrey GK, Lima HC, Titus RG 1998. Analysis of the immune responses of mice to infection with Leishmania braziliensis. Infect Immun 66: 827-829.
9. Gicheru MM, Olobo JO, Anjili CO 1997. Heterologous protection by Leishmania donovani for Leishmania major infections in the vervet monkey model of the disease. Exp Parasitol 85: 109-116.
10. Lainson R, Bray RS 1966. Studies on the immunology and serology of leishmaniasis. II. Cross-immunity experiments among different forms of American cutaneous leishmaniasis in monkeys. Trans R Soc Trop Med Hyg 60: 526-512.
11. Lainson R, Shaw JJ 1977. Leishmaniasis in Brazil: XII. Observations on cross-immunity in monkeys and man infected with Leishmania mexicana mexicana, L. m. amazonensis, L. braziliensis braziliensis, L. b. guvanensis and L. b. panamensis. J Trop Med Hyg 80: 29-35.
12. 2 production and antileishmanial capacity of human cultured monocytes mediated by IFN-γ. J Immunol 143: 3020-3024.
13. Liew FY, O'Donnell CA 1993. Immunology of leishmaniasis. Adv Parasitol 32: 161-259.
14. Liew FY, Millott S, Li Y, Lelchuk R, Chan WL, Ziltener H 1989. Macrophage activation by interferon-γ from host-protective T cells is inhibited by interleukin (IL) 3 and IL-4 produced by disease-promoting T cells in leishmaniasis. Eur J Immunol 19: 1227-1232.
15. Lima HC, Bleyenberg J, Titus RG 1997. A simple method for quantifying Leishmania in tissues of infected animals. Parasitol Today 13: 80-82.
16. Maryanski J, van Snick J, Cerottini J-C, Boon T 1982. Immunogenic variants obtained by mutagenesis of mouse mastocytoma P 815. III. Clonal analysis of the syngeneic cytolytic T lymphocyte response. Eur J Immunol 12: 401-405.
17. Melby PC 1991. Experimental leishmaniasis in humans: review. Rev Infect Din 13: 1009-1017.
18. Mosmann TR, Coffman RL 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Ann Rev Immunol 7: 145-173.
19. Murray HW, Rubin BY, Rothermel CD 1983. Killing of intracellular Leishmania donovani by lymphokine-stimulated human monocytes. Evidence that Interferon γ is the activating lymphokine. J Clin Invest 72: 1506-1510.
20. Nacy CA, Fortier AH, Meltzer MS, Buchmeier NA, Gray PW 1985. Macrophage activation to kill Leishmania major. Activation of macrophages for intracellular destruction of amastigotes can be induced by both recombinant interferon-γ and non-interferon lymphokines. J Immunol 135: 3505-3511.
21. Neal RA, Hale C 1983. A comparative study of susceptibility of inbred and outbred mouse strains compared with hamsters to infection with New World cutaneous leishmaniases. Parasitology 87: 7-13.
22. Neal RA, Reeves A, Peters W 1990. Leishmania infecting man and wild animals in Saudi Arabia. 7. Partial protection of mice against Leishmania major by prior infection with L. arabica. Trans R Soc Trop Med Hyg 84: 233-238.
23. Perez H, Arredondo B, Machado R 1979. Leishmania mexicana and Leishmania tropica: cross immunity in C57BL/6 mice. Exp Parasitol 48: 9-14.
24. Peters W, Bryceson A, Evans DA, Neal RA, Kaye P, Blackwell J, Killick-Kendrick R, Liew FY 1990. Leishmania infecting man and wild animals in Saudi Arabia. 8. The influence of prior infection with Leishmania arabica on challenge with L. major in man. Trans R Soc Trop Med Hyg 84: 681-689.
25. Puentes SM, da Silva RP, Sacks DL, Hammer CH, Joiner K 1990. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9. J Immunol 145: 4311-4316.
26. Reed SG, Scott P 1993. T-cell and cytokine responses in leishmaniasis. Curr Opin Immunol 5: 524-531.
27. Reiner SL, Locksley RM 1995. The regulation of immunity to Leishmania major. Ann Rev Immunol 13: 151-177.
28. Samuelson J, Lerner E, Tesh R, Titus R 1991. A mouse model of Leishmania braziliensis braziliensis infection produced by co-injection with sand fly saliva. J Exp Med 173: 49-54.
29. Soares MBP, David JR, Titus RG 1997. An in vitro model for infection with Leishmania major that mimics the immune response in mice. Infect Immun 65: 2837-2845.
30. Titus RG, Kelso A, Louis JA 1984. Intracellular destruction of Leishmania tropica by macrophages activated with macrophage activating factor/interferon. Clin Exp Immunol 55: 157-165.
31. Titus RG, Theodos CM, Shankar A, Hall LR 1994. Interactions between Leishmania major and macrophages, Immunol Series 60: 437-459.